Please assess the completion status of the following clinical trial:

Trial Title: Techniques to Reduce the Severity and Frequency of Emergent Reactions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Be at least 18 years of age~* Required need for procedural sedation and analgesia~Exclusion Criteria:~* Age\< 18~* Hypertension~* Raised Intracranial pressure~* Major psychological disorders~* Procedures involving laryngel manipulations~* History of Laryngeal sapsm History of adverse reactions to ketamine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group 1 (Type: ACTIVE_COMPARATOR): Packet 1: The Physician will be asked to instruct the patient as empathetically and confidently as possible, that the drug the patient will be given will make them feel no pain, cause them to forget the procedure, and allow them to dream the dream of their choice.
- Control Arm (Type: OTHER): Half of the participants will receive the sedation medication with the usual conversation while the physician is giving the medication to the patient. The other half of the participants will have a more positive conversation, (which is the study intervention), with the physician while being given the medication. Both group's emergence reactions, if any, will be compared to see if the positive conversation reduced the side effect.

Based on this trial design, predict the completion outcome and termination type (if applicable).